Bacchus Pneumonitis
Marta Sánchez-Martelesa, María del Mar Rodero-Roldána, Mar Garcés-Sotillosb, Juan Ignacio Pérez-Calvoa
aInternal Medicine Department, “Lozano Blesa” University Hospital, Zaragoza, Spain
bAllergy Department, “Lozano Blesa” University Hospital, Zaragoza, Spain
Doi: 10.12890/2014_000087 - European Journal of Case Reports in Internal Medicine - © EFIM 2014
Received: 13/05/2014
Accepted: 16/06/2014
Published: 18/07/2014

How to cite this article: Sánchez-Marteles M, del Mar Rodero-Roldán M, Garcés-Sotillos M, Pérez-Calvo JI. Bacchus Pneumonitis, EJCRIM 2014;1:doi: 10.12890/2014_000087

Conflicts of Interests: The authors declare that they have no conflicts of interest in this research

ABSTRACT

Objective: Interstitial lung diseases (ILD) are a group of pathologies of undetermined frequency that require a broad differentialdiagnosis and continue to pose a challenge for clinicians.

Observations: We present a clinical case of a 17-year-old male with acute interstitial pneumonitis, lung aspergillosis and foreign body lung granulomatosis after carbon monoxide (CO) intoxication. As far as we know, no similar cases have beenreported in the literature.

Conclusions: ILD require a broad differential diagnosis, which is of great importance to prognosis.

LEARNING POINTS

KEYWORDS

Pneumology, infectious diseases, internal medicine

CASE REPORT

A 17-year-old male of Romanian origin and no relevant medical history was treated by emergency staff following an accidentat work. He had fallen into a wine storage container several meters deep and had lostconsciousness. On arrival at the emergency unit, he had severe respiratory failure and was transferred to the intensive care unit (ICU) with a presumptivediagnosis of acute non-cardiogenic pulmonary oedema. Carboxyhaemoglobin levels were normal. After stabilization in the ICU, the patient was transferred to the internal medicineward with a diagnosis of carbon monoxide (CO) intoxication. He was febrile (up to 39ºC), alert and pale. Tachycardia was 110 beats per minute (bpm) and jugular distension was not present. The respiratory rate was 28 per minute, accompanied by severe breathing difficulty. Cracklingsounds could be heard from the middle and inferior lobes. The remainder of the physical examination was unremarkable. Partial oxygen pressure (PO2) was 53 mmHg, PCO2 was 41 mmHg, oxygen saturation was 88%, and levels of bicarbonate and lactic acid were normal. Chest x-ray showed an alveolar-interstitial pattern (Fig. 1).

Figure 1 (click to enlarge)

Fig. 1 - Chest x-ray showing an alveolar-interstitial pattern

Microbiology of sputum, including investigation for Koch's bacilli, yielded negative results. High-resolution thorax CT revealed well-defined centrilobular lung nodules 2–5 mm in diameter coveringthe lung parenchyma, particularly in the right hemithorax. Lesions were attributed to hypersensitivity pneumonitis (Fig. 2).

Figure 2 (click to enlarge)

Fig. 2 - Well-defined centrilobular lung nodules affecting the entire pulmonary parenchyma, mainly in the right hemithorax

Immunological tests were positive for IgG precipitins and Aspergillus fumigatus, and negative for autoantibodies (anti-centromere, anti-SSA/Ro, anti-DNAds, anti-RNP, anti-histone, anti-neutrophil cytoplasmic, anti-smooth muscleantibody). There was no history of previous exposure to Aspergillus. The CD4/CD8 ratio was 1.52. Empirical treatment for tuberculosis (TB) wasbegun, followed by intravenous steroids administered according to the guidelines of the Spanish Pneumology and Thoracic Surgery Society (Sociedad Española de Neumología y Cirugía Torácica, SEPAR) for interstitial pneumopathies1. Treatment was well tolerated. Respiratory function tests revealed a severe restrictive pattern. Bronchoscopy was contra-indicated due tosevere respiratory failure. Consequently, an open lung biopsy was performed under anaesthesia. Pathological analysis of lung tissue showed a developmental-phaseforeign body giant cell granuloma, without central necrosis There were ubiquitous deposits of amorphous, slightly fibrillar foreign bodies, which we identified as grape traces (Fig. 3).

Figure 3 (click to enlarge)

Fig. 3 - Foreign body giant cell granulomas (top arrow) and amorphous matter, refractive, yellow and blue (bottom arrow)

Lung biopsy samples were cultivated, yielding a growth of A. fumigatus. PCR for mycobacterium complex was negative. Anti-TB treatment was discontinued and voriconazole was added to corticosteroids, according to Spanish guidelines[1,2]. The patient experienced a gradual clinical and radiological recovery, reaching NYHA functional class IIand a respiratory in the British Medical Research Council (MCR)[3]. After discharge, respiratory function tests remained stable. It was significant thatthe CO diffusing capacity (DLCO) was 67.6% and the Tiffenau index 69.37.

DISCUSSION

Accidental CO poisoning is an occupational hazard of the wine fermentation process,frequently leading to a fatal outcome. Within minutes, inhalation of CO levels above 6–10% in air causes shortness of breath, dizziness, sweating, nausea andloss of consciousness. Treatment involves the administration of highly concentrated oxygen[4]. Although broadly different in aetiology, diffuse ILD or interstitial pneumopathies are a group of diseases with similar clinical, radiological and functionalfeatures at presentation. The main differences allowing reliable classification are pathological changes involving the alveolar-interstitial structures. Suchchanges are associated with over 150 aetiological agents, although their epidemiology has not yet been clearly defined. From a clinical point of view,the most prominent symptom is dyspnoea during exertion or at rest, and cough. Other systemic signs such as fever, malaise, fatigue or arthromyalgia are also frequent. A wide range of diagnostic tests is required to rule outalternative diagnoses and correctly classify the subtype of ILD[1,5,6]. One of the causes of ILD is hypersensitivity pneumonitis, which is caused by theinhalation of organic matter. Diagnosis is based on several criteria, such as provocation tests, detection of specific serum antibodies, and clinicalimprovement after eliminating exposure to the allergen. Our patient failed to fulfil any of these criteria[1,5]. Most cases of pulmonary foreign body granulomatosis are associated with talc or cellulose used as excipients in medication or illicitdrugs. To the best of our knowledge, there are no reported cases of ILD secondary to the foreign body reaction caused by the inhalation of grape traces[7,8]. The clinical pattern of our patient was similar to other cases of ILD. The most prominent symptoms were cough, sputum production and dyspnoea. Thereare fewer reported cases of ILD in which acute respiratory failure, fibrosis or emphysema have been caused by foreign body inhalation. Diagnostic work-upusually includes bronchoscopy and lung biopsy7. Treatment in the acute phase is based on general life-support measures, while in the chronicphase, the effectiveness of corticoids has not been proven, and the results of immunomodulators are based on animal models[7,8]. We propose for this peculiar aetiology of ILD the name ‘Bacchus pneumonitis',since it was caused by the full immersion of the patient in a deep wine storage container.

References
  1. Xaubet A, Ancochea J, Blanquer R, Montero C, Morell F, Rodríguez Becerra E, et al. Grupo de Investigación en Enfermedades Pulmonares Intersticiales Difusas. Area de Técnicas y Transplante. SEPAR. Diagnóstico y tratamiento de las enfermedades pulmonares intersticiales difusas. Arch Bronconeumol 2003;39:580–600.
  2. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327–360.
  3. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;1:257–266.
  4. Viqueira JA. Toxicidades por oxígeno, monóxido de carbono y dióxido de carbono. JANO 2008;1707:23–30.
  5. Wells AU, Hirani N, British Thoracic Society Interstitial Lung Disease Guideline Group. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008;63 (Suppl. V):1–58.
  6. Zacharisen MC, Fink JN. Hypersensitivity pneumonitis and related conditions in the work environment. Immunol Allergy Clin N Am 2011; 31:769–786.
  7. Conen D, Schilter D, Bubendorf L, Brutsche MH, Leuppi JD. Interstitial lung disease in an intravenous drug user. Respiration 2003; 70:101–103.
  8. Low SU, Nicol A. Talc induced granulomatosis. J Clin Pathol 2006;59:223–224.